Ketoess-DS Tablet contains Alpha Ketoanalogue (NA), a specialized nutritional supplement indicated primarily for patients with chronic kidney disease (CKD) to support renal function and delay progression of renal impairment. Alpha Ketoanalogue serves as a nitrogen-free precursor to essential amino acids, facilitating protein synthesis while minimizing nitrogenous waste accumulation, thereby reducing the metabolic burden on compromised kidneys. Ketoess-DS is typically administered in conjunction with a low-protein diet to optimize nutritional status without exacerbating uremic symptoms. The tablet aids in maintaining a balanced amino acid profile, preventing protein-energy malnutrition, and improving overall metabolic parameters in CKD patients. It is particularly beneficial in stages 3 to 5 of CKD, including those undergoing conservative management prior to dialysis initiation. Dosage and administration should be individualized based on renal function, dietary protein intake, and clinical response, under strict medical supervision. Adverse effects are generally uncommon but may include gastrointestinal disturbances or hypersensitivity reactions. Ketoess-DS should be used cautiously in patients with hepatic impairment or metabolic disorders affecting amino acid metabolism. Regular monitoring of renal function, nutritional status, and electrolyte balance is recommended during therapy. This product is not intended for use as a sole protein source but as an adjunct to dietary management in CKD.